Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 26, 2018
Accession Number: 0001193125-18-222516
Submission Type: POS AM
CIK: 0001316175
Company Name: Anthera Pharmaceuticals Inc
File Number: 333-175095